Skip to search formSkip to main contentSkip to account menu

pirmenol

Known as: 2-Pyridinemethanol, alpha-(3-(2,6-dimethyl-1-piperidinyl)propyl)-alpha-phenyl-, monohydrochloride, cis-(+-)-, cis-alpha-(3-(2,6-dimethyl-1-piperidinyl)propyl)-alpha-phenyl-2-pyridinemethanol monohydrochloride 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
1999
Review
1999
The Vaughan Williams classification has been used widely by clinicians, cardiologists and researchers engaged in antiarrhythmic… 
Highly Cited
1993
Highly Cited
1993
  • J. Mason
  • The New England journal of medicine
  • 1993
  • Corpus ID: 21003702
BACKGROUND The relative efficacies of various antiarrhythmic drugs in the treatment of ventricular tachyarrhythmias are not well… 
1990
1990
To assess the cardiovascular profiles of pirmenol, a new antiarrhythmic drug, and to compare them with those of disopyramide… 
Highly Cited
1989
Highly Cited
1989
ESVEM (Electrophysiologic Study Versus Electrocardiographic Monitoring) is an ongoing multicenter trial supported by the National… 
Review
1989
Review
1989
1988
1988
Using two-stage coronary ligation-, digitalis- and adrenaline-induced canine ventricular arrhythmias, antiarrhythmic effects of… 
1983
1983
Abstract: Twelve patients having frequent premature ventricular complexes (PVCs) averaging more than 60 per hour received a… 
Highly Cited
1982
Highly Cited
1982
Pirmenol (CI-845), a new antiarrhythmic drug, was studied for the first time in humans to establish a minimum effective i.v. dose… 
1982
1982
We examined the hemodynamic effects of pirmenol, a new antiarrhythmic drug, for the first time in man. Right and left heart… 
1982
1982
The oral form of pirmenol has not been administered to man. Pirmenol was given by mouth to eight patients with chronic, stable…